U.S. Vaccine Market to Expand at 4.3% CAGR from 2014 to 2020, Initiatives to Eradicate Lethal Diseases Drive Market

A vaccine is a biological preparation that delivers active acquired immunity against a particular disease. It is administered either through needle injections, orally, or by aerosol. Vaccination involves the administration of a killed or weakened organism into the body that develops immunity in the body against that organism. Vaccines cause immunization; there are also some diseases that provide immunization after recovery from the disease.

Download Exclusive Sample of this Report: http://bit.ly/2c4g7cp

According to the Centers for Disease Control and Prevention (CDC), vaccination programs across the U.S. have been successful in the eradication of lethal diseases such as polio, smallpox, and diphtheria, while diseases such as tetanus, rubella, and measles have been largely controlled. Vaccination administered as a preventive measure has helped save the lives of millions of individuals in the U.S.

In the U.S., strict regulations imposed by the federal government, which mandate immunization against certain diseases is driving the U.S. vaccines market. Meanwhile, the rising incidence of zoonotic diseases among animals and the high risk of transmitting its associated infection to humans is propelling the growth of the animal vaccines market.

Moreover, widespread pet ownership in the country has significantly contributed to the growth of the animal vaccines market in the U.S. Factors such as the rising consumption of poultry and meat products and recent approvals of Prime Pac PRRS+ and Once PMH IN have also bolstered the growth of the U.S. animal vaccine market.

On the flip side, the stringent regulatory framework that governs the approval process of vaccines in the U.S. impedes the growth of this market to a certain extent. Moreover, the high cost involved in the research and development of new vaccines will also hamper the growth of this market during the forecast period.

The report segments the U.S. vaccine market into human vaccines and animal vaccine to analyze this market during the forecast period. By vaccine type, the U.S. human vaccine market is divided into adult and pediatric vaccines. By antigen, this market is divided into hepatitis, meningococcal, human papillomavirus (HPV), influenza, pneumococcal, combination vaccines, and others.

Browse Research Report: http://bit.ly/2cbsQsX

The U.S. market for animal vaccines is segmented into companion animal and livestock vaccines. The companion animal vaccines segment is further sub-segmented into canine and feline. In 2013, canine vaccines held a slightly larger share than feline vaccines due to the higher average cost of canine vaccines.

Some of the leading players in the U.S. vaccines market are Novartis International AG, Merck & Co. Inc., Sanofi, GlaxoSmithKline plc, and Merck & Co.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.